Skip to main content

Table 4 variables correlated with occurrence of complications in the studied groups

From: Predictors of residual hepatic reserve and hepatic decompensation in cirrhotic patients after ablated hepatocellular carcinoma treated by DDAs or systemic therapy

DAAs treated group

ALT

0.194

0.002

Albumin

-0.518

0.0001

Platelet count

-0.349

0.0001

Gamma globulin

0.584

0.0001

Ammonia

0.776

0.0001

LSM

0.615

0.0001

LV

-0.737

0.0001

Sorafenib treated group

creatinine

0.245

0.0001

PDW/MPV

0.566

0.0001

Prothrombin concentration

-0.335

0.0001

MELD

0.495

0.0001

Ammonia

0.833

0.0001

LSM

0.356

0.0001

LV

-0.758

0.0001